StaphOff Biotech


StaphOff Biotech Inc. is an innovative pharmaceutical company dedicated to developing medical products that prevent or stop resistant Staphylococcal infections. They utilize a unique approach with molecules like CEN-101 and CEN-103 that weaken bacteria's ability to resist immune defenses and traditional antibiotics, by inhibiting communication, biofilm formation, and toxin production, thereby enhancing the body's immune response and antibiotic efficacy.

Industries

biotechnology
medical
pharmaceutical

Nr. of Employees

small (1-50)

StaphOff Biotech

Hopkinton, Massachusetts, United States, North America


Products

whISOBAX tincture

A tannin‑rich plant extract tincture formulated for topical and potential dietary uses; provided in multiple package sizes and claimed to have higher active concentration than standard extracts.


Services

Supply of GMP-grade tannin-rich extract (tincture)

Provision of a liquid, high‑tannin plant extract for topical, nasal or formulation use, produced in a GMP-certified, FDA-registered facility.

Access to peer-reviewed research and collaboration

Curated library of peer-reviewed publications and willingness to discuss research related to anti-virulence and anti-biofilm technologies.

Expertise Areas

  • Anti-virulence therapeutics
  • Biofilm-targeting therapies
  • Preclinical in vivo efficacy testing
  • Topical formulation development
  • Show More (6)

Key Technologies

  • Quorum sensing inhibition
  • Anti-biofilm agents
  • Topical and systemic drug formulation
  • High-tannin plant extract processing
  • Show More (5)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.